Press Releases Tanvex BioPharma, Inc.

Equities

6541

KYG8676P1037

End-of-day quote Taiwan S.E. Other stock markets 03:30:00 14/05/2024 am IST			5-day change	1st Jan Change
42.2 ^TWD	-3.10%		-5.59%	-35.18%

14/03	Tanvex BioPharma, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
06/02	Tanvex BioPharma, Inc. Announces the Appointment of James Williamson as Accounting Officer	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Tanvex BioPharma : On behalf of the major subsidiary, Tanvex Biologics Corporationto announce the change of Accounting officer	19/22/19	PU
Tanvex BioPharma : Represent subsidiary Tanvex BioPharma USA,Inc. to announce BLA resubmission for TX01(Neupogen Biosimilar)	15/22/15	PU
Tanvex BioPharma : The Company has been required by TWSE to announce the financial data according to the regulations	04/22/04	PU
Tanvex BioPharma : Represent subsidiary Tanvex BioPharma USA,Inc. to announce the result of FDA inspection for TX05(Herceptin Biosimilar)(supplementary)	01/22/01	PU
Tanvex BioPharma : Represent subsidiary Tanvex BioPharma USA,Inc. to announce the result of FDA inspection for TX05(Herceptin Biosimilar)	01/22/01	PU
Tanvex BioPharma : Represent subsidiary Tanvex BioPharma USA,Inc. to announce that TX01(Neupogen Biosimilar) got Drug Establishment Licence from Health Canada	25/22/25	PU
Tanvex BioPharma : Announcement of the Board of Directors' resolution on the appointment of corporate governance officer	15/22/15	PU
Tanvex BioPharma : Announcement of new appointment of the Company's Remuneration Committee.	15/22/15	PU
Tanvex BioPharma : Announcement of the Resolution of Annual General Meeting to Approve of Lifting of Non-Competition Restrictions for Board Director.	17/22/17	PU
Tanvex BioPharma : The Announcement of Resolutions of 2022 Annual General Shareholders’ Meeting(Add any other proposals)	17/22/17	PU
Tanvex BioPharma : Announcement of One Newly By-Elected Independent Director at 2022 General Shareholders' Meeting of Tanvex	17/22/17	PU
Tanvex BioPharma : The Announcement of Resolutions of 2022 Annual General Shareholders’ Meeting	17/22/17	PU
Tanvex BioPharma : The Company and TaiMed Biologics form a business alliance to offer CDMO services in the development and manufacturing of ADC and BsAb.	14/22/14	PU
Tanvex BioPharma : Announced on behalf of subsidiary,Tanvex Biologics Corporation,directors and supervisor change	22/22/22	PU
Tanvex BioPharma : The Board of Directors approved the convening of the 2022 Annual General Shareholders' Meeting(add new discussion matters)	22/22/22	PU
Tanvex BioPharma : Announcement of the progress of the company's committed items at the time when the stock was listed on TWSE.	12/22/12	PU
Tanvex BioPharma : Resolution by the board of directors not to distribute dividends	21/22/21	PU
Tanvex BioPharma : The Board approved to issue Employees' Restricted Share Award	21/22/21	PU
Tanvex BioPharma : The time, venue, and agenda of the 2022 annual general meeting.	21/22/21	PU
Tanvex BioPharma : Subsidiary Tanvex BioPharma USA,Inc. that the company has resolved to conduct issuance of new shares through cash capital increase	18/22/18	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Tanvex BioPharma, Inc.

Equities

6541

KYG8676P1037

Press Releases

Filters